Bioteque Cash Flow Conversion Efficiency
Bioteque cash flow conversion efficiency. Based on the latest financial reports, Bioteque (4107) has a cash flow conversion efficiency ratio of 0.036x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$127.00 Million ≈ $4.00 Million USD) by net assets (NT$3.53 Billion ≈ $111.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Bioteque (2006–2025)
Cash flow conversion efficiency of Bioteque from 2006 to 2025. This chart illustrates how Bioteque's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Bioteque for real-time trading data and today's change.
Bioteque Cash Flow Conversion Ratio Explained
Bioteque cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Bioteque Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioteque ranked by their cash flow conversion efficiency. Also see market cap of Bioteque for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Emergent Biosolutions Inc
NYSE:EBS
|
0.164x |
|
Nu Skin Enterprises Inc
NYSE:NUS
|
0.020x |
|
BGF Retail Co Ltd
KO:027410
|
0.007x |
|
Tian Zheng International Precision Machinery Co Ltd
TWO:6654
|
-0.065x |
|
Fourlis Holdings S.A.
AT:FOYRK
|
0.155x |
|
Fagerhult AB
ST:FAG
|
0.049x |
|
ESAF Small Finance Bank
NSE:ESAFSFB
|
-0.810x |
|
Stellar V Capital Corp. Unit
NASDAQ:SVCCU
|
0.000x |
Annual Cash Flow Conversion Efficiency for Bioteque (2006–2025)
The table below shows the annual cash flow conversion efficiency of Bioteque from 2006 to 2025. Review Bioteque (4107) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$3.61 Billion ≈ $113.65 Million |
NT$664.20 Million ≈ $20.93 Million |
0.184x | -9.82% |
| 2024-12-31 | NT$3.44 Billion ≈ $108.41 Million |
NT$702.62 Million ≈ $22.14 Million |
0.204x | -2.69% |
| 2023-12-31 | NT$3.19 Billion ≈ $100.51 Million |
NT$669.40 Million ≈ $21.09 Million |
0.210x | -1.30% |
| 2022-12-31 | NT$3.03 Billion ≈ $95.52 Million |
NT$644.58 Million ≈ $20.31 Million |
0.213x | +27.00% |
| 2021-12-31 | NT$2.80 Billion ≈ $88.32 Million |
NT$469.25 Million ≈ $14.78 Million |
0.167x | -29.71% |
| 2020-12-31 | NT$2.66 Billion ≈ $83.94 Million |
NT$634.51 Million ≈ $19.99 Million |
0.238x | -4.95% |
| 2019-12-31 | NT$2.49 Billion ≈ $78.39 Million |
NT$623.41 Million ≈ $19.64 Million |
0.251x | +25.93% |
| 2018-12-31 | NT$2.31 Billion ≈ $72.90 Million |
NT$460.41 Million ≈ $14.51 Million |
0.199x | +26.34% |
| 2017-12-31 | NT$2.14 Billion ≈ $67.32 Million |
NT$336.51 Million ≈ $10.60 Million |
0.157x | -14.05% |
| 2016-12-31 | NT$2.08 Billion ≈ $65.45 Million |
NT$380.63 Million ≈ $11.99 Million |
0.183x | -9.79% |
| 2015-12-31 | NT$1.90 Billion ≈ $59.79 Million |
NT$385.43 Million ≈ $12.14 Million |
0.203x | +3.65% |
| 2014-12-31 | NT$1.88 Billion ≈ $59.28 Million |
NT$368.71 Million ≈ $11.62 Million |
0.196x | +17.08% |
| 2013-12-31 | NT$1.62 Billion ≈ $50.91 Million |
NT$270.44 Million ≈ $8.52 Million |
0.167x | +17.11% |
| 2012-12-31 | NT$1.28 Billion ≈ $40.44 Million |
NT$183.44 Million ≈ $5.78 Million |
0.143x | +19.48% |
| 2011-12-31 | NT$1.24 Billion ≈ $39.10 Million |
NT$148.43 Million ≈ $4.68 Million |
0.120x | -19.79% |
| 2010-12-31 | NT$1.24 Billion ≈ $39.17 Million |
NT$185.39 Million ≈ $5.84 Million |
0.149x | +7.17% |
| 2009-12-31 | NT$1.25 Billion ≈ $39.47 Million |
NT$174.32 Million ≈ $5.49 Million |
0.139x | -40.46% |
| 2008-12-31 | NT$1.19 Billion ≈ $37.37 Million |
NT$277.23 Million ≈ $8.73 Million |
0.234x | +71.56% |
| 2007-12-31 | NT$1.17 Billion ≈ $36.95 Million |
NT$159.77 Million ≈ $5.03 Million |
0.136x | +36.92% |
| 2006-12-31 | NT$778.61 Million ≈ $24.53 Million |
NT$77.47 Million ≈ $2.44 Million |
0.099x | -- |
About Bioteque
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter… Read more